CTNNB1 and hepatocellular carcinoma: To extrapolate our findings to additional β-catenin-mutated HCC preclinical models that we have previously reported, we next tested LNP-CTNNB1 in the S45Y-mutant-β-catenin-Met (β-M) model, which represents 11% of human HCC27.